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Summary: Using a qPCR TaqMan Array Card, we found that cytomegalovirus and Mycobacterium 
tuberculosis were the most frequently detected targets in the blood of patients with sepsis in Uganda 
and both were independently associated with increased mortality. 
 
Running title: Etiology of sepsis in Uganda 
 
Abstract 
Background. Knowledge of causes of sepsis in sub-Saharan Africa is limited. A better understanding of 
the microbiology of bloodstream infections could improve outcomes.  
Methods. We used a quantitative PCR (qPCR)-based TaqMan Array Card (TAC) to directly test for 43 
targets from whole blood. We analyzed 336 cryopreserved specimens from adult Ugandans with sepsis 
enrolled in a multi-site study; 84% were HIV-infected. We compared qPCR TAC results with blood culture 
and determined the association of qPCR with study participant outcomes using logistic regression. 
Results. The most frequently detected targets were cytomegalovirus (CMV, n=139, 41%), 
Mycobacterium tuberculosis (TB, n=70, 21%), Plasmodium (n=35, 10%), and Streptococcus pneumoniae 
(n=31, 9%). Diagnostic performance varied by target with qPCR sensitivity averaging 61±28% and 
specificity 98±3% versus culture. In multivariable analysis, independent factors associated with in-
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hospital mortality included CMV viremia (adjusted odds ratio [aOR] 3.2, 95% CI, 1.8-5.5; p<.01) and TB 
qPCR-positivity, whether blood culture-positive (aOR 4.6, 95% CI, 2.1-10.0; p<.01) or blood culture-
negative (aOR 2.9, 95% CI, 1.2-6.9; p=.02). 
Conclusions. Using qPCR TAC on direct blood specimens, CMV and TB were the most commonly 
identified targets and were independently associated with increased in-hospital mortality. qPCR TAC 
screening of blood for multiple targets may be useful to guide triage and treatment of sepsis in sub-
Saharan Africa. 
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Introduction 
Sepsis is a common cause of hospital admission, morbidity, and mortality in sub-Saharan Africa (1;2). In 
resource-limited settings such as much of sub-Saharan Africa, little is known about the epidemiology of 
sepsis. A better understanding of the microbiology of sepsis would help clinicians in the region to select 
appropriate antimicrobial therapy, avoid unnecessary therapy, and thereby improve outcomes. Unlike 
sepsis cohorts in North America and Europe, there is a high prevalence (60-90%) of HIV infection in 
patients with sepsis in sub-Saharan Africa which is likely to have an impact on the etiology of their 
infections (3-5). 
 
The spectrum of possible bloodstream infections is broad, and many are not identified through standard 
culture methods (6). For example, there is a high rate of Mycobacterium tuberculosis (TB) bloodstream 
infections in HIV-infected patients (7;8), but mycobacterial blood cultures are rarely performed. Other 
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pathogens such as Leptospira, Coxiella, and Brucella are identified through serology which often 
requires initial and follow-up samples that are collected several weeks later (9-12). Viral testing is 
virtually never performed other than in specialized settings (5;13-15). 
 
Given the high cost, low yield, and slow turnaround time of standard bacterial cultures, molecular 
techniques offer broad diagnostic potential. We recently described the development of a TaqMan Array 
Card (TAC) for the investigation of acute febrile illnesses using blood samples (16). This technology 
allows for simultaneous, single-plexed, quantitative PCR-based amplification of multiple targets 
including bacteria, viruses, fungi, and protozoa with sensitivity and specificity of 88% and 99%, 
respectively, compared to the cognate assays (16). Here we used the qPCR TAC to determine the 
underlying cause of infection in patients enrolled in a prior study of fluid resuscitation in septic patients 
in Uganda (17). We compared the results of qPCR TAC with prior clinical microbiology testing and 
examined the association of qPCR TAC results with the important clinical outcome of in-hospital 
mortality. 
 
Methods 
Specimens. We obtained a convenience sample of available cryopreserved EDTA-whole blood 
specimens from 336 adult patients aged ≥18 years with sepsis enrolled in a fluid resuscitation study 
from the medical casualty units of Mulago National Referral Hospital and Masaka Regional Referral 
Hospital in Uganda from May 2008 to May 2009 (17). Written informed consent was obtained from each 
patient or a surrogate if the patient could not provide consent. At the time of enrollment, we obtained 
baseline demographic and clinical data including antibiotics received. We collected blood from eight 
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healthy Ugandan volunteers as negative controls. All whole blood samples were cryopreserved at -80°C 
until they were tested in 2015-2016.  
 
Target detection using qPCR TAC. We incorporated primers and probes for 43 targets and two extrinsic 
controls on the TAC as previously described (Supplemental Tables 1 and 2) (16). Any quantification cycle 
(Cq) result of <40 was considered positive. Lower Cq values indicate higher quantity of target material 
present in the sample.  
Cryptococcal antigen testing. We tested a convenience sample of available plasma specimens from 265 
participants for the presence of cryptococcal antigen using lateral flow assay kits (Immuno-Mycologics 
Inc., Norman, OK, USA) following the manufacturer's instructions. 
 
Statistical analysis. We determined sensitivity and specificity for qPCR TAC results compared to 
standard culture results. We summarized participant characteristics as percentage for categorical 
variables and median with interquartile range (IQR) for continuous variables. We compared proportions 
with the Chi-square test and compared continuous variables with the Mann-Whitney U test. We 
evaluated relationships between qPCR TAC results and in-hospital mortality with logistic regression and 
adjusted for age, sex, and HIV infection. P values were two-tailed, and <.05 was considered significant 
(SPSS, Version 22.0; IBM Corp, Armonk, New York). 
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Demographics and qPCR TAC results. Of the 336 participants, the median (IQR) age was 34 (27-40) 
years, 175 (52%) were female, 282 (84%) were HIV-infected, and 90 (27%) died in-hospital (Table 1). The 
clinical and laboratory data from the convenience sample were similar to those from the total enrolled 
cohort (Supplemental Table 3) (17). All 336 samples yielded valid qPCR TAC results as described in 
Supplemental Table 2. We tested positive samples again for the relevant targets with PCR assays that 
generated longer amplicons (16).  As seen previously, ~80% (277 of 346) of the TAC results were 
sequence-confirmed, and those that were able to be confirmed by long amplicon sequencing had 
significantly lower Cq values than those that were not (31.1±4.7 vs 36.6±1.7, p<.01) (16). 
No target was detected in any of the 8 Ugandan healthy volunteer controls. We detected at least one 
target in 245 of 336 participants (72%, Table 2). The most frequently detected targets were 
cytomegalovirus (CMV, n=139, 41%), TB (n=70, 21%), Plasmodium species (n=35, 10%), and 
Streptococcus pneumoniae (n=31, 9%). Excluding CMV, 138 (41%) participants had one target, 18 (5%) 
had two targets, and 1 (0.3%) had three targets identified by qPCR. Of the 139 cases of CMV viremia, 
there were 66 (40%) cases of bacterial coinfection including 28 (42%) that were identified by both qPCR 
and culture, 25 (38%) that were identified by qPCR only, and 13 (20%) that were identified by culture 
only. Compared to previously performed blood cultures, qPCR TAC performance varied by target 
averaging 61% sensitivity and 98% specificity (Table 3). Overall, culture-positive samples had lower Cqs 
(31.4±3.1, n=65) than those that were culture-negative (33.1±3.0, n=61, p<.01). 
 
qPCR TAC results and in-hospital mortality. CMV viremia was associated with in-hospital mortality, with 
57 of 138 (41%) CMV-positive participants dying in hospital compared to 33 of 195 (17%) CMV-negative 
participants (Odds Ratio 3.5, 95% confidence interval [CI] 2.1-5.7, p<.01). We did not have any pathology 
Results 
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data to determine end-organ involvement by CMV versus reactivation viremia in the setting of critical 
illness. There were 40 (12%) TB qPCR-positive/culture-positive cases, 30 (9%) TB qPCR-positive/culture-
negative cases, 29 (9%) TB qPCR-negative/culture-positive cases, and 237 (71%) TB qPCR-
negative/culture-negative cases. The in-hospital mortality for these groups was 55%, 43%, 31%, and 
20%, respectively (Table 4). In multivariable analysis, CMV viremia (adjusted Odds Ratio 3.19, 95% CI 
1.83-5.54, p<.01) and a positive TB qPCR result with either a concurrent negative (adjusted Odds Ratio 
2.85, 95% CI 1.18-6.88, p=.02) or positive (adjusted Odds Ratio 4.60, 95% CI 2.12-9.98, p<.01) TB culture 
result were independently associated with in-hospital mortality (Table 4).  
 
The in-hospital mortality for S. pneumoniae qPCR-positive cases (n=31) was 33%  compared to 13% in-
hospital mortality for qPCR-negative/culture-negative cases (adjusted Odds Ratio 2.18, 95% CI 0.89-5.30, 
p=.09). Plasmodium qPCR-positive cases had lower mortality (6%); however, there was not a statistically 
significant difference in mortality when compared to qPCR-negative/culture-negative cases (adjusted 
Odds Ratio 0.25, 95% CI 0.06-1.16, p=.08). Of the two Plasmodium infected participants that died, one 
had CMV viremia, and the other had S. pneumoniae coinfection.  
 
Seventeen of 265 participants (86% HIV-infected) had positive cryptococcal antigen (CrAg) assays; 6 
were also Cryptococcus qPCR-positive and 5 were Cryptococcus blood culture-positive. All positive CrAg 
results occurred in HIV-infected participants. In-hospital mortality for these participants was 59% (CrAg), 
83% (Cryptococcus TAC), and 60% (Cryptococcus blood culture). The sensitivity of qPCR for identifying 
Cryptococcus versus culture was 80%. The sensitivity of qPCR for identifying CrAg assay positive cases 
was 29% and specificity was 100%. The qPCR sensitivity improved to 55% (6 of 11) for cases with CrAg 
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assay titer ≥1:2560. Four of 5 cases with low CrAg assay titers (<1:80) had a second causative pathogen 
identified in blood culture. 
 
Quantity of amplified DNA and in-hospital mortality. The quantities of TB, CMV, and S. pneumoniae 
DNA as measured by qPCR (Cq) appeared to directly correlate with mortality (Figure 1). In multivariable 
analysis that included continuous Cq values for CMV and TB, we found an adjusted Odds Ratio of in-
hospital mortality of 1.4 (95% CI 1.2-1.7, p<.01) and 1.6 (95% CI 1.2-1.9, p<.01) for each ten-fold increase 
in quantity for CMV and TB, respectively. 
 
Antimicrobial therapy and in-hospital mortality. There were 43 different combinations of antibacterial 
therapy administered to 324 of 336 (96%) participants in our study. The most frequently administered 
antibacterial regimen was ceftriaxone monotherapy which was administered to 77 (23%) participants. 
Antifungal therapy was administered to 25 (9%) participants and anti-mycobacterial therapy was 
administered to 32 (11%) participants. No study participants received anti-viral therapy other than anti-
retroviral therapy. There were 120 participants with positive blood cultures. Of the 100 participants with 
positive blood cultures and known antibiotics, 39 (39%) received appropriate antibiotics and of the 45 
participants with negative blood cultures and positive TAC results, 29 (64%) received appropriate 
antibiotics. 
 
Mortality from TB infection remained high despite anti-TB therapy. There were 13 (13.1%) of 99 
confirmed TB cases (by culture, qPCR, or both) who received empirical anti-TB therapy, 4 (31%) of whom 
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died in-hospital. This mortality contrasts with 48% in-hospital mortality among TB cases who did not 
receive anti-TB therapy but the difference is not statistically significant (Odds Ratio 2.07, 95% CI 0.60-
7.34, p=.25). Excluding TB, 53 of 71 (75%) patients with a positive qPCR result for a bacterial infection 
that received appropriate antibiotics had an in-hospital mortality of 23% compared with 33% in those 
who did not receive appropriate antibiotics (Odds Ratio 0.59, 95% CI 0.18-1.89, p=0.37).  
 
Discussion 
In this work, we demonstrate the utility of a multi-target qPCR TAC in the evaluation of sepsis in sub-
Saharan Africa. We found CMV and TB were the most commonly identified TAC targets in the blood of 
patients with sepsis in Uganda and were independently associated with increased in-hospital mortality. 
Future use of qPCR TAC to screen blood for multiple targets may be useful for therapeutic triage of 
individual patients, outbreak investigations, and determination of local epidemiology through use in 
sentinel laboratories. 
 
There are abundant data that indicate that the time to appropriate therapy for bloodstream 
infections correlates with improved mortality (18-20). However, given the large number of 
potential pathogens, there is a need for improved syndromic diagnostic methods. Blood culture, 
considered the gold standard for microbiological diagnosis, is expensive, requires several days to 
yield a result, and is affected by antibiotic pre-exposure which is common in many settings. 
Serologic tests are often unavailable. PCR tests are faster and can be designed for virtually any 
pathogen. Previous studies using commercial PCR-based methods to detect pathogens directly in 
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blood including SeptiFast®, SepsiTest™ and IRIDICA BAC BSI Assay used >2mL of blood and revealed 
only a 48-84% sensitivity compared with blood culture (21). This low to moderate sensitivity range 
presumably reflects low numbers of pathogens in blood, as has been clearly demonstrated for 
Salmonella enterica Typhi (22).    
 
Other challenges to PCR in blood are the typically low sample volumes and inhibitory substances within 
blood. In this context, we were not surprised to observe a 61% overall sensitivity of qPCR TAC versus 
culture, particularly given the sub-microliter volumes of nucleic acid required for qPCR TAC. We were 
limited to less than 2mL of whole blood per sample in this study and we would advocate using larger 
volumes to improve sensitivity. Another factor was that these blood samples were stored ~7 years prior 
to testing, thus specimen degradation could have occurred. However, it has been shown that DNA in 
blood samples frozen at -80oC for 16 months was preserved well (23). 
 
A systematic review of commercial PCR methods used to identify bacteria and fungi in blood found 81-
86% specificity versus blood culture, in other words a 14-19% “false positive” rate (21). An important 
finding of ours is that the qPCR-positive/culture-negative specimens were not false information but 
were clinically significant. Specifically, a TB qPCR-positive case, even if culture-negative, exhibited a high 
mortality. In fact, the TB qPCR-positive/culture-negative mortality was higher than and maintained 
statistically significant prognostic information over the TB qPCR-negative/culture-positive mortality. This 
finding combined with the inverse relationship between Cq values and mortality suggests a higher 
burden of infection for TB qPCR-positive/culture-negative cases compared to TB qPCR-negative/culture-
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positive cases. Therefore we feel qPCR-positive/culture-negative results in blood should be re-examined 
and not reflexively dismissed. 
 
As for the TB qPCR TAC performance itself versus culture, our results are similar to most other studies. A 
study found a sensitivity of 42% and specificity of 100% for PCR compared to a gold standard of TB 
culture positivity from any clinical specimen (24). A small study from Malawi reported a 56% 
concordance between Xpert MTB/RIF PCR detection from blood and blood culture in HIV-infected 
patients with a high clinical suspicion for TB (25). In a study from Uganda, PCR identified TB in blood with 
a sensitivity and specificity of 33% and 97% respectively when using 2 mL samples and 71% and 96% 
respectively when using 10 mL samples (26).  
 
The 50% TB mortality we observed was also expected. This finding is similar to studies from Malawi, 
South Africa, Tanzania, and Uganda which found an associated mortality of 21-50% (7;27-29). In our 
study, few patients received anti-TB therapy. A trend towards lower mortality was observed in TB 
patients who received anti-TB therapy versus those who did not, although mortality remained high and 
the difference was not statistically significant. In 317 HIV-infected sputum smear-negative patients 
presenting with clinical danger signs in Uganda, mortality was 20% if patients received empiric anti-TB 
therapy compared to 36% mortality if they did not (30). In another study of 34 patients in Uganda with 
confirmed mycobacteremia, the proportion of patients who died at one year was significantly lower in 
those who were receiving anti-TB therapy (23%) at the time of culture positivity compared with those 
who were not receiving anti-TB therapy (58%) (28). These results suggest that early identification and 
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treatment of mycobacteremia can improve outcomes, and TB should be raised on the differential 
diagnosis of inpatients with sepsis in TB endemic settings. 
 
CMV was the most frequent qPCR TAC target found in this patient population and CMV viremia was 
independently associated with mortality. In critically ill patients, CMV reactivation is known to be 
associated with increased mortality; however, CMV viremia does not usually require treatment (31-34). 
A randomized clinical trial of ganciclovir for critically ill CMV-seropositive adults showed no difference in 
mortality between treatment groups (34). CMV seroprevalence is approximately 80% in sub-Saharan 
Africa, and CMV viremia in dried blood spots was independently associated with increased risk of death 
in HIV-infected patients from Tanzania (35-37). Although we did not have clinical data regarding end-
organ damage due to CMV viremia, given the high number of bacterial coinfections in CMV viremia 
cases, we believe the CMV viremia was likely a prognostic marker but not causal for mortality. In 
support of the association between CMV reactivation and underlying disease severity is our finding that 
lower Cq values were associated with increased mortality in our multivariable analysis. 
 
The three leading qPCR TAC targets we detected, CMV, TB and S. pneumoniae, all exhibited an inverse 
relationship between Cq and in-hospital mortality. Therefore, PCR positivity may reflect a higher burden 
of infection, which is associated with mortality. Overall S. pneumoniae was associated with considerably 
lower mortality than TB perhaps because standard therapy for critically ill patients would be likely to 
treat this pathogen. However S. pneumoniae showed a high mortality similar to TB at its highest 
bacterial load (i.e., lowest Cq), perhaps because of overwhelming infection. We presume the low 
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mortality associated with Plasmodium positivity was because this may have represented incidental 
asymptomatic parasitemia (38).  
 
There were also some cases of Cryptococcus, Dengue virus, and Rickettsia species identified by qPCR 
TAC. While Cryptococcus can be readily identified by the antigen test, cryptococcosis remains associated 
with high mortality rates (39). Since 4 of 5 cases with low CrAg assay titers (<1:80) had a second 
causative pathogen identified in blood culture, it is unlikely that cryptococcosis was the etiology of 
sepsis in these cases. Dengue and Rickettsia are not easily recognized or considered as pathogens in 
critically ill patients in this region. However, spotted fever and typhus group rickettsiosis have been 
identified in febrile patients in Tanzania and Rickettsia species are commonly found in dog fleas in 
Uganda (12;40). Rickettsial infections are treatable with doxycycline and a better understanding of 
which patients are likely to present with a rickettsial infection could help guide empiric therapy. 
 
There were limitations to this study. While the overall sample size of 336 was substantial, on a per 
pathogen basis we did not have sufficient power to conduct all analyses. Although we tested for 43 
pathogens, there are still others that one might want to include. Not all qPCR TAC targets could be 
confirmed through standard testing due to specimen availability. With regard to CMV specifically, 
detection of CMV in whole blood is generally greater than that obtained in plasma, and plasma has been 
advocated as a better sample type for measuring CMV response to therapy, however that was not our 
goal or of great relevance to this setting (41;42). Additionally, the qPCR TAC platform is well-suited to 
high throughput testing but less well-suited to clinical care because it requires a manual nucleic acid 
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extraction method and tests 8 samples at once. Although molecular testing is expensive (~$50-100 
reagent costs per sample), blood culture and other methodologies are also costly and imperfect.  
 
In summary, in a predominantly HIV-infected population with sepsis, we confirmed that TB is the leading 
cause of bacteremia which is associated with high mortality. CMV viremia was also independently 
associated with mortality. In total we identified 19 different targets including many that would not be 
treated with standard empiric antibiotics (e.g. Rickettsia species) or require treatment (e.g. Dengue 
virus). We believe this work demonstrates the principle that a pan-molecular quantitative assay that 
screens for multiple targets in blood would be useful to provide therapeutic and prognostic information, 
particularly in settings with a high burden of HIV and other infectious diseases. For example, the qPCR 
TAC assay could identify the need for early TB therapy, CMV viremia as a marker for early mortality, and 
S. pneumoniae as an indicator of intermediate mortality (33%); or if nothing is positive with a large 
panel, this could portend a better prognosis. 
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Figure legend 
Figure 1. Association of Cytomegalovirus (CMV), M. tuberculosis, Plasmodium, S. pneumoniae, and DNA 
quantity as determined by quantification cycle with mortality for 336 adult patients admitted to hospital 
with sepsis in Uganda. The x-axis shows the Cq ranges, while the y-axis shows the in-hospital mortality 
associated with each pathogen according to the corresponding Cq cutoff. The dark bar indicates the 
mortality rate for TAC negative patients for all the pathogens interrogated. 
 
  
Downloaded from https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciy472/5032704
by Liverpool School of Tropical Medicine user
on 20 June 2018
  
 
Table 1. Clinical and laboratory features of 336 adult hospitalized patients with sepsis in Uganda. 
 
Clinical or laboratory variable median (IQR) or n (%) 
Age, years 34 (27-40) 
Women 175 (52%) 
HIV-infected 282 (84%) 
CD4+ T cells/𝜇L  61 (13-176) 
Lactate, mmol/L 3.9 (3.0-4.9) 
In-hospital mortality 90 (27%) 
 
 
  
Downloaded from https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciy472/5032704
by Liverpool School of Tropical Medicine user
on 20 June 2018
  
 
Table 2. qPCR TAC detection in blood from 336 adult patients admitted to hospital with sepsis in 
Uganda. 
 
Pathogen, n (%) 
Total 
(n=336) 
HIV-infected* 
(n=282) 
HIV-negative 
(n=50) 
CMV 139 (41) 129 (46) 8 (16) 
Mycobacterium tuberculosis 70 (21) 63 (22) 6 (12) 
Plasmodium species 35 (10) 18 (6) 17 (34) 
Streptococcus pneumoniae 31 (9) 27 (10) 4 (8) 
Dengue 17 (5) 16 (6) 1 (2) 
Escherichia coli 16 (5) 11 (4) 5 (10) 
Cryptococcus neoformans 6 (2) 6 (2) 0 (0) 
Rickettsia species 6 (2) 4 (1) 2 (4) 
Pseudomonas aeruginosa 4 (1) 2 (0.7) 2 (4) 
Klebsiella pneumoniae 4 (1) 4 (1) 0 (0) 
Staphylococcus aureus 4 (1) 3 (1) 1 (2) 
Toxoplasma gondii 4 (1) 3 (1) 1 (2) 
Acinetobacter baumannii 3 (0.9) 3 (1) 0 (0) 
Salmonella species 3 (0.9) 3 (1) 0 (0) 
Hepatitis E 2 (0.6) 1 (0.4) 1 (2) 
Leptospira species 2 (0.6) 2 (0.7) 0 (0) 
Brucella species 1 (0.3) 1 (0.4) 0 (0) 
Coxiella burnetii 1 (0.3) 1 (0.4) 0 (0) 
Salmonella enterica Typhi 1 (0.3) 1 (0.4) 0 (0) 
No specimens were positive for: Bartonella species, Crimean-Congo hemorrhagic fever, Chikungunya, 
Enterovirus, Group B Streptococcus, Haemophilus influenzae, Hantavirus, Histoplasma capsulatum, 
Listeria monocytogenes, Leishmania species, Mycobacterium avium complex, Marburg, Neisseria 
meningitidis, Nipah, O’nyong’nyong, Rift Valley Fever, Sudan, Trypanosoma brucei, West Nile, Yersinia 
pestis, Yellow Fever, or Zika. 
*HIV serostatus was known for 332 (99%) of the 336 study participants 
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Table 3. Comparison between qPCR TAC and blood culture from 336 adult patients admitted to hospital 
with sepsis in Uganda. Average PCR Cycle of Quantification (Cq) and standard deviation are shown in 
parentheses. 
 
Pathogens 
Culture positive Culture negative 
qPCR + qPCR - sensitivity qPCR + qPCR - specificity 
M. tuberculosis 
40 
(31.2±3.4) 
29 58% 30 
(32.1±2.9) 
237 89% 
S. pneumoniae 
16 
(31.3±2.9) 
4 80% 15 
(32.8±3.2) 
301 95% 
Cryptococcus 
4 
(30.9±2.0) 
1 80% 
 
2 
(31.3±4.6) 
329 99% 
Salmonella 
2 
(31.8±1.3) 
2 50% 1 
(38.2) 
331 100% 
S. aureus 
1 
(33.5) 
3 25% 3 
(33.1±2.2) 
329 99% 
E. coli 
3 
(34.8±0.6) 
0 100% 13 
(34.6±1.8) 
320 96% 
Pseudomonas 
1 
(33.1) 
0 100% 4 
(36.6±2.3) 
331 99% 
K. pneumoniae    4 332 99% 
A. baumannii    3 333 99% 
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Total 65 41 61% 61 3193 98% 
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Table 4. Univariable and multivariable analysis of predictors of in-hospital mortality for 336 adult patients admitted to hospital with sepsis in 
Uganda 
 
Characteristic 
Number 
(%) 
Mortality, 
n (%) 
Odds 
ratio 
95% 
Confidence 
interval 
P 
Adjusted 
odds ratio 
95% 
Confidence 
interval 
P 
Age, per year - - 1.01 0.98-1.03 0.64 1.00 0.97-1.03 0.83 
Women 175 (52) 41 (23) 0.68 0.42-1.11 0.12 0.86 0.49-1.51 0.60 
HIV-infected  282 (84) 84 (30) 3.73 1.43-9.75 0.01 1.62 0.56-4.70 0.37 
CMV qPCR+ 139 (41) 57 (41) 3.46 2.09-5.72 <0.01 3.19 1.83-5.54 <0.01 
qPCR and culture neg 68 (20) 9 (13) 1.0 - - 1.0 - - 
TB qPCR neg and culture + 29 (9) 9 (31) 1.24 0.54-2.83 0.61 1.87 0.75-4.67 0.18 
TB qPCR+ and culture neg 30 (9) 13 (43) 2.24 1.04-4.83 0.04 2.85 1.18-6.88 0.02 
TB qPCR+ and culture + 40 (12) 22 (55) 4.04 2.05-7.98 <0.01 4.60 2.12-9.98 <0.01 
S. pneumoniae qPCR+ 31 (9) 10 (33) 1.39 0.63-3.11 0.41 2.18 0.89-5.30 0.09 
Other bacteria qPCR+ 42 (13) 9 (21) 0.71 0.32-1.54 0.38 0.73 0.30-1.78 0.49 
Plasmodium qPCR+ 35 (10) 2 (6) 0.15 0.03-0.62 0.01 0.25 0.06-1.16 0.08 
+ = positive; neg = negative 
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Figure 1. 
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